Clinical management of prostatic intraepithelial neoplasia as diagnosed by extended needle biopsies

BJU International

Volumn 91, Issue 4, 2003, Pages 350-354

  San Francisco, I F ^a   Olumi, A F ^a   Kao, J ^a   Rosen, S ^a   Dewolf, W C ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Benign prostate; Extended needle biopsy; Prostate cancer; Prostatic intraepithelial neoplasia

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NEEDLE BIOPSY; ORGAN SIZE; PALPATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; TESTOSTERONE BLOOD LEVEL;

AGED; BIOPSY, NEEDLE; COHORT STUDIES; DISEASE-FREE SURVIVAL; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0037349877     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2003.04081.x     Document Type: Article

References (30)

1. Bostwick DG. High grade prostatic intraepithelial neoplasia. The most likely precursor of prostate cancer. Cancer 1995; 75 (Suppl): 1823-35
2. Drago JR, Mostofi FK, Lee F. Introductory remarks and workshop summary. Urology 1989; 34 (Suppl): 2-3
3. McNeal JE, Bostwick DG. Intraductal dysplasia, a premalignant lesion of the prostate. Hum Path 1986; 17: 64-71
4. Graham SD Jr, Bostwick DG, Hoisaeter A et al. Report of the committee on staging and pathology. Cancer 1992; 70 (Suppl): 359-61
5. Bostwick DG, Amin MB, Dundore P, Marsh W, Schultz DS. Architectural patterns of high grade prostatic intraepithelial neoplasia. Hum Path 1993; 24: 298-310
6. Hoedemaeker RF, Kranse R, Rietbergen JB, Boeken Kruger AE, Schröder FH, Van der Kwast TH. Evaluation of prostate needle biopsies in a population-based screening study: the impact of borderline lesions. Cancer 1999; 85: 145-52
7. Cheville JC, Resnicek MJ, Bostwick DG. The focus of 'atypical glands, suspicious for malignancy' in prostatic needle biopsy specimens. Incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice. Am J Clin Path 1997; 108: 633-40
8. Renshaw AA, Santis WF, Richie JP. Clinicopathological characteristics of prostatic adenocarcinoma in men with atypical prostate needle biopsies. J Urol 1998; 159: 2018-21
9. Orozco R, O'Dowd G, Kunnel B, Miller MC, Veltri RW. Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States. Urology 1998; 51: 186-95
10. Langer JE, Rovner ES, Coleman BG et al. Strategy for repeat biopsy of patients with prostatic intraepithelial neoplasia detected by prostate needle biopsy. J Urol 1996; 155: 228-31
11. Wills ML, Hamper UM, Partin AW, Epstein JI. Incidence of high grade prostatic intraepithelial neoplasia in sextant needle biopsy specimens. Urology 1997; 49: 367-73
12. Fowler JE Jr, Bigler SA, Lynch C, Wilson SS, Farabaugh PB. Prospective study of correlations between biopsy-detected high grade prostatic intraepithelial neoplasia, serum prostate specific antigen concentration, and race. Cancer 2001; 91: 1291-6
13. Bostwick DG, Qian J, Frankel K. The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies. J Urol 1995; 154: 1791-4
14. Kim SC, Weiser AC, Nadler RB, Pins MR, Campbell SC. The changing incidence of high grade prostatic intraepithelial neoplasia: clinical implications. J Urol 2000; 163 (Suppl): 279, A1239
15. O'Dowd GJ, Miller C, Orozco R, Veltri RW. Analysis of repeated biopsy results within 1 year after a noncancer diagnosis. Urology 2000; 55: 553-9
16. Davidson D, Boswick DG, Qian J et al. Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies. J Urol 1995; 154: 1295-9
17. Raviv G, Janssen T, Zlotta AR, Descamps F, Verhest A, Schulman CC. Prostatic intraepithelial neoplasia: influence of clinical and pathological data on the detection of prostate cancer. J Urol 1996; 156: 1050-5
18. Keetch DW, Humphrey P, Stahl D, Smith DS, Catalona WJ. Morphometric analysis and clinical followup of isolated prostatic intraepithelial neoplasia in the needle biopsy of the prostate. J Urol 1995; 154: 347-51
19. Aboseif S, Shinohara K, Weider N, Narayan P, Carroll PR. The significance of prostatic intra-epithelial neoplasia. Br J Urol 1995; 76: 355-9
20. Brawer MK, Bigler SA, Sohlberg OE, Nagle RB, Lange PH. Significance of prostatic intraepithelial neoplasia on prostate needle biopsy. Urology 1991; 38: 103-7
21. Sheperd D, Keetch D, Humphrey P, Smith DS, Stahl D. Repeat biopsy strategy in men with isolated prostatic intraepithelial neoplasia on prostate needle biopsy. J Urol 1996; 156: 460-3
22. Park S, Shinohara K, Groosfeld GD, Carroll PR. Prostatic cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy. J Urol 2001; 165: 1409-14
23. Weinstein MH, Epstein JI. Significance of high grade prostatic intraepithelial neoplasia on needle biopsy. Hum Path 1993; 24: 624-9
24. Ellis WJ, Brawer MK. Repeat prostate needle biopsy: who needs it? J Urol 1995; 153: 1496-8
25. Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997; 157: 199-203
26. Kao J, Upton M, Zhang P, Rosen S. Individual prostate biopsy core embedding facilitates maximal tissue representation. J Urol 2002; 168: 496-9
27. Lefkowitz GK, Sidhu GS, Torre P, Lepor H, Taneja SS. Is repeat prostate biopsy for high-grade prostate intraepithelial neoplasia necessary after routine 12-core sampling? Urology 2001; 58: 999-1003
28. Smith DS, Catalona WJ. Rate of change in serum prostate-specific antigen as a method of prostate cancer detection. J Urol 2002; 152: 1163-7
29. Catalona WJ, Partin AW, Slawin KM et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease. A prospective multicenter clinical trial. JAMA 1998; 279: 1542-7
30. Kronz JD, Allan CH, Shaikh AA, Epstein JI. Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: data on men with more than one follow-up biopsy. Am J Surg Path 2001; 25: 1079-85